13.76
+0.18
+(1.33%)
At close: January 31 at 8:09:04 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-88,591.00
-41,564.00
-28,588.00
-34,035.00
-54,144.51
Investing Cash Flow
-3,867.00
-11,288.00
-587.00
-107.00
247.91
Financing Cash Flow
220,601.00
43,248.00
64,964.00
26,320.00
63,416.70
End Cash Position
204,368.00
83,679.00
93,283.00
57,494.00
65,316.48
Interest Paid Supplemental Data
--
360.00
1,626.00
423.00
820.89
Capital Expenditure
-3,867.00
-11,290.00
-592.00
-107.00
-752.09
Issuance of Capital Stock
163,131.00
24,238.00
54,461.00
21,710.00
71,225.40
Issuance of Debt
57,460.00
41,744.00
19,767.00
10,410.00
--
Repayment of Debt
-106.00
-22,371.00
-10,811.00
-10,830.00
-6,769.42
Free Cash Flow
-92,458.00
-52,854.00
-29,180.00
-34,142.00
-54,896.59
12/31/2020 - 2/7/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6YG.MU Immunocore Holdings plc
31.40
+2.61%
2L9.SG Blueprint Medicines Corp
107.90
-0.55%
63E.MU Onward Medical NV
6.34
-6.49%
ASEP.CN ASEP Medical Holdings Inc.
0.0650
-13.33%
63E.F Onward Medical N.V.
6.50
-2.11%
5CV.F CureVac N.V.
3.6520
-1.78%
ONWD.BR Onward Medical N.V.
6.36
+0.95%
SANN.SW Santhera Pharmaceuticals Holding AG
17.12
+4.39%
HOTH Hoth Therapeutics, Inc.
1.2600
-1.56%
BBIO BridgeBio Pharma, Inc.
34.21
-4.89%